3.2000
-0.0700
(-2.14%)
At close: January 10 at 4:00:00 PM EST
3.2000
0.00
(0.00%)
After hours: January 10 at 7:49:53 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-7,998.9740
-8,604.1090
-12,649.0210
-11,739.6200
-11,454.4260
Investing Cash Flow
-24.8620
--
-13.0730
-11.7890
-7.1470
Financing Cash Flow
7,473.0290
3,663.5060
76.8210
19,058.0010
24,676.6490
End Cash Position
9,772.5890
8,446.1580
13,359.6150
26,043.8970
18,676.6630
Income Tax Paid Supplemental Data
49.8860
20.7300
16.0430
7.7270
4.0210
Interest Paid Supplemental Data
247.8180
552.0580
857.4110
668.7150
34.4060
Capital Expenditure
--
--
-13.0730
-11.7890
-7.1470
Issuance of Capital Stock
4,799.8360
11,587.2790
79.3540
19,705.6470
14,615.9900
Issuance of Debt
--
--
--
--
10,000.0000
Repayment of Debt
-686.4360
-7,000.0000
--
-6.1490
-7.5160
Free Cash Flow
-7,998.9740
-8,604.1090
-12,662.0940
-11,751.4090
-11,461.5730
12/31/2020 - 4/4/1994
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PTIX Protagenic Therapeutics, Inc.
0.4800
-14.13%
THAR Tharimmune, Inc.
2.0500
-5.53%
EVFM Evofem Biosciences, Inc.
0.0100
-9.09%
KZIA Kazia Therapeutics Limited
1.5800
-5.95%
NLSP NLS Pharmaceutics AG
2.3200
-3.73%
SCNI Scinai Immunotherapeutics Ltd.
3.5300
+1.44%
NCNA NuCana plc
1.1300
-1.74%
PCSA Processa Pharmaceuticals, Inc.
0.8512
-1.49%
RNAZ TransCode Therapeutics, Inc.
3.2800
-4.37%
LGVN Longeveron Inc.
1.7900
-1.10%